Gold Sponsor
PALL Biotech
Drawing on nearly 70 years of experience supporting cGMP manufacturing of vaccines and protein-based therapeutics, Pall Biotech’s innovative cell therapy platform is designed to help our customers overcome the challenges associated with the production of live cells for therapies. Pall Biotech is dedicated to helping our customers achieve their cell therapy commercialization goals.
Associated Experts
Company: PALL Biotech
Job Title: Senior Global Marketing Manager, Cell & Gene Therapy
Company: PALL Biotech
Job Title: Vice President and General Manager, Single-Use Technologies
Company: PALL Biotech
Associated Content
Novel single-use valve design increases efficiency and decreases risk of contamination
There are many challenges facing biopharmaceutical companies during commercial manufacturing. These challenges drive continual improvements in both manufacturing strategy and the associated tools or technologies used. For instance, pricing pressure has increased the need to reduce manufacturing costs. In addition, ... Continued
Integrating bioprocessing steps to improve efficiency and reduce cost
In this podcast, we interviewed Dr. Rick Morris, Senior Vice President, R&D, Biotech, Pall Life Sciences, about integrating bioprocessing steps to improve efficiency, reduce cost and address current challenges in the industry. Specifically we looked at how upstream and downstream can be more integrated ... Continued
Scalable Viral Vector Upstream Process for AAV Gene Therapy Manufacturing
Gene therapy is an exciting area of medicine that has the potential to treat a wide range of diseases for which no other treatments are available. One of the key components of successful gene therapy manufacturing is the production of ... Continued
Cell Harvesting Technologies – Which is best for your process?
Cell harvesting is a critical step in connecting upstream monoclonal antibody production with downstream purification. Selecting the best cell harvesting technology based on the characteristics of the cell culture process can be challenging. This decision is made early in process ... Continued
Large Scale Adenovirus Production for Gene Therapy Manufacturing
Gene therapy is one of the most promising developments in medicine. It has the potential to treat many diseases by using a gene-modifying technology to repair, replace or correct genetic damage in the body. Last year was an important year ... Continued
Shape Matters – An Innovative Design for Single-use Bioreactors
For many years cylindrical stainless steel tanks have been used in biopharmaceutical production. The primary reason for the cylindrical shape was that it provided the mechanical stability required for high-pressure steam sterilization. In recent years single-use systems have become more widely ... Continued
A Look at the Current State of Continuous Bioprocessing
Introduction Recently, BioProcess International in conjunction with Pall Life Sciences published an informative supplement titled, “Is Continuous Bioprocessing the Future? ”. The publication contains 12 articles covering various aspects of continuous bioprocessing as well as additional articles on enabling technologies. I ... Continued
Cool Tool – Pall AcroPrep™ Advance 96-well Long Tip Filter Plate Offers Efficiency and Flexibility in Nucleic Acid Purification
A Single Plate for Multiple Applications Purified RNA or DNA is required for most molecular biology experiments and their isolation is often one of the first steps in disease pathways research. So RNA and DNA purification is a regular part of ... Continued
Options for Increasing Output and Reducing Footprint in Adherent Cell Culture
Introduction Adherent cell culture is often used in the manufacture of biologic products, including vaccines. Historically, the surface for cells to adhere to has been provided either by a two-dimensional (2D) system such as roller bottles, T-flasks, cell factories or cell ... Continued
Viral Vector Production in the Integrity iCELLis Single-Use Fixed-Bed Bioreactor, From Bench Scale to Industrial Scale
A. Lennaertz (alenaertz@atmi.com), S. Knowles (sknowles@atmi.com), J.C. Drugmand, J. Castillo, ATMI LifeSciences Introduction Wild-type or recombinant viruses used as vaccines and human Gene Therapy vectors are an important development tool in modern medicine. Some have demonstrated high potential such as lentivirus, paramyxovirus and ... Continued
How to Ensure Integrity and Sterility of Single-Use Assemblies for Manufacturings
Introduction Single-use systems have many clear advantages, however, one challenge is ensuring the integrity of these plastic bags and components. Microscopic breaches of integrity, even those that cannot be seen, can allow microbial ingress. Possible breaches extend beyond just the bags, ... Continued